END-STAGE KIDNEY DISEASE
Clinical trials for END-STAGE KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new END-STAGE KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for END-STAGE KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to calm inflammation in kidney dialysis patients
Disease control Not yet recruitingThis early-stage trial tests a drug called CSL300 (clazakizumab) in 24 Chinese adults with end-stage kidney disease who are on dialysis. The drug is an antibody that blocks interleukin-6, a protein involved in inflammation. The main goal is to see how the drug moves through the b…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: PHASE1 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Dialysis patients may get better vaccine protection with a common transplant drug
Disease control Not yet recruitingThis study tests whether taking a short course of the drug sirolimus (Rapamycin) can improve how well older adults on hemodialysis respond to flu and RSV vaccines. Sixty participants will receive the vaccines plus sirolimus at different times. The goal is to see if this approach …
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Central Adelaide Local Health Network Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug aims to stop kidney rejection
Disease control Not yet recruitingThis early study tests a new medicine called TNX-1500 in 5 people who get a kidney transplant. The goal is to see if it is safe and can help prevent the body from rejecting the new kidney. Participants will be followed for one year to check for side effects and signs of rejection…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Ayman Al Jurdi, MD • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Dialysis showdown: which blood thinner works best?
Knowledge-focused Not yet recruitingThis study looks at two ways to prevent blood clots during dialysis in people with end-stage kidney disease. Twenty adults will try both methods—one using standard heparin and the other using a citrate-based approach—to see which causes less inflammation and removes waste better.…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can a salt substitute help kidney patients? small study aims to find out
Knowledge-focused Not yet recruitingThis pilot study will test whether a potassium-containing salt substitute is safe for people with end-stage kidney disease on hemodialysis. Twenty participants will use the salt substitute for 16 days and regular table salt for 16 days, with a break in between. Researchers will m…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC